<i>Clostridium difficile</i>-associated disease

The aim of review. To generalize accumulated data on C. difficile infection, diagnostics, treatment and prevention of C.difficile-associated disease.Summary. C.difficile is unthrifty on breeding grounds, obligate anaerobic, gram-positive, sporeforming, cytotoxin-producing bacterium. C. difficile tox...

Full description

Saved in:
Bibliographic Details
Main Authors: V. T. Ivashkin, O. S. Shifrin, A. S. Tertycnhy, Ye. A. Poluektova, T. L. Lapina, O. S. Lyashenko, K. V. Ivashkin
Format: Article
Language:Russian
Published: Gastro LLC 2015-12-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/1033
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860133451530240
author V. T. Ivashkin
O. S. Shifrin
A. S. Tertycnhy
Ye. A. Poluektova
T. L. Lapina
O. S. Lyashenko
K. V. Ivashkin
author_facet V. T. Ivashkin
O. S. Shifrin
A. S. Tertycnhy
Ye. A. Poluektova
T. L. Lapina
O. S. Lyashenko
K. V. Ivashkin
author_sort V. T. Ivashkin
collection DOAJ
description The aim of review. To generalize accumulated data on C. difficile infection, diagnostics, treatment and prevention of C.difficile-associated disease.Summary. C.difficile is unthrifty on breeding grounds, obligate anaerobic, gram-positive, sporeforming, cytotoxin-producing bacterium. C. difficile toxins A and B are protein molecules, classified as glycosyltransferases. Influence of toxins induces damage and inflammation of intestinal wall due to impairment of intestinal epithelial barrier, stimulation of proinflammatory cytokine production, apoptosis and necrosis of epithelial cells. Basic clinical symptom of C. difficileassociated disease is diarrhea or diarrhea with hematochezia (according to severity of the case). Feces of patients with diarrhea are sampled for C. difficile toxin detection. Nowadays there are several laboratory diagnostic tests for Clostridial infection: testing for C. difficile glutamate dehydrogenase, enzyme-linked immunoassay, polymerase chain reaction for toxigenic strain of C. difficile. However, which of these methods may be considered to be «the gold standard» is unclear yet. Metronidazole, vancomycin, dioctaedric smectite and probiotics are used for treatment of C. difficile infection. Rational use of antibiotics, shortening of hospital stay terms whenever possible, especially for patients of 65 years of age and older is recommended to reduce the risk of clostridial infection development. Preliminary, routine and general cleaning should be carried out in medical institutions as well as the cleaning of hands of medical personnel and medical stock according to sanitary-and-epidemiologic rules and specifications.Conclusion. From the beginning of XXI century in many countries of the world prompt increase of C. difficile-associated disease cases is marked. This disease is the most frequent cause of intrahospital diarrhea resulting in significant mortality. This is why it is extremely important to be able to diagnose, treat in due terms this disease and to carry out prophylactic procedures.
format Article
id doaj-art-6bacc335ce084d03bb5a795bd99c535d
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2015-12-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-6bacc335ce084d03bb5a795bd99c535d2025-02-10T16:14:34ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732015-12-01256517640<i>Clostridium difficile</i>-associated diseaseV. T. Ivashkin0O. S. Shifrin1A. S. Tertycnhy2Ye. A. Poluektova3T. L. Lapina4O. S. Lyashenko5K. V. Ivashkin6State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationThe aim of review. To generalize accumulated data on C. difficile infection, diagnostics, treatment and prevention of C.difficile-associated disease.Summary. C.difficile is unthrifty on breeding grounds, obligate anaerobic, gram-positive, sporeforming, cytotoxin-producing bacterium. C. difficile toxins A and B are protein molecules, classified as glycosyltransferases. Influence of toxins induces damage and inflammation of intestinal wall due to impairment of intestinal epithelial barrier, stimulation of proinflammatory cytokine production, apoptosis and necrosis of epithelial cells. Basic clinical symptom of C. difficileassociated disease is diarrhea or diarrhea with hematochezia (according to severity of the case). Feces of patients with diarrhea are sampled for C. difficile toxin detection. Nowadays there are several laboratory diagnostic tests for Clostridial infection: testing for C. difficile glutamate dehydrogenase, enzyme-linked immunoassay, polymerase chain reaction for toxigenic strain of C. difficile. However, which of these methods may be considered to be «the gold standard» is unclear yet. Metronidazole, vancomycin, dioctaedric smectite and probiotics are used for treatment of C. difficile infection. Rational use of antibiotics, shortening of hospital stay terms whenever possible, especially for patients of 65 years of age and older is recommended to reduce the risk of clostridial infection development. Preliminary, routine and general cleaning should be carried out in medical institutions as well as the cleaning of hands of medical personnel and medical stock according to sanitary-and-epidemiologic rules and specifications.Conclusion. From the beginning of XXI century in many countries of the world prompt increase of C. difficile-associated disease cases is marked. This disease is the most frequent cause of intrahospital diarrhea resulting in significant mortality. This is why it is extremely important to be able to diagnose, treat in due terms this disease and to carry out prophylactic procedures.https://www.gastro-j.ru/jour/article/view/1033c. difficile-associated diseasepseudomembranous colitistoxins a and b of c. difficiletreatmentvancomycinmetronidazoledioctaedric smectiteflorasan d
spellingShingle V. T. Ivashkin
O. S. Shifrin
A. S. Tertycnhy
Ye. A. Poluektova
T. L. Lapina
O. S. Lyashenko
K. V. Ivashkin
<i>Clostridium difficile</i>-associated disease
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
c. difficile-associated disease
pseudomembranous colitis
toxins a and b of c. difficile
treatment
vancomycin
metronidazole
dioctaedric smectite
florasan d
title <i>Clostridium difficile</i>-associated disease
title_full <i>Clostridium difficile</i>-associated disease
title_fullStr <i>Clostridium difficile</i>-associated disease
title_full_unstemmed <i>Clostridium difficile</i>-associated disease
title_short <i>Clostridium difficile</i>-associated disease
title_sort i clostridium difficile i associated disease
topic c. difficile-associated disease
pseudomembranous colitis
toxins a and b of c. difficile
treatment
vancomycin
metronidazole
dioctaedric smectite
florasan d
url https://www.gastro-j.ru/jour/article/view/1033
work_keys_str_mv AT vtivashkin iclostridiumdifficileiassociateddisease
AT osshifrin iclostridiumdifficileiassociateddisease
AT astertycnhy iclostridiumdifficileiassociateddisease
AT yeapoluektova iclostridiumdifficileiassociateddisease
AT tllapina iclostridiumdifficileiassociateddisease
AT oslyashenko iclostridiumdifficileiassociateddisease
AT kvivashkin iclostridiumdifficileiassociateddisease